Begin Main Content Area


Emergency Use Authorization for Paxlovid
CHIP Provider Enrollment Claim Denial Alert (PDF)
Revised USP Compounding Standards (PDF)    

New Compounding Regulations (PDF)
Clarification of Opioid Continuing Education Requirement Under ABC-MAP* (PDF)
Evidence-Based Prescribing:  Tools You Can Use to Fight the Opioid Epidemic (PDF)
Act 6 of 2018 Reporting of Sanctions and Criminal Proceedings, Suspension and Civil Penalties (PDF)
Fentanyl Safety Recommendations (PDF)
Continuing Education Requirements for Pharmacist License Renewal (PDF)
DHS Training for Electronic Enrollment in CHIP (PDF)
FDA Warns of Potentially Counterfeit Drugs from Philadelphia Area Pharmacy
Opioid Education for Pharmacist Applications and Renewals Submitted After July 1, 2017 (PDF)

*NEW* - Drug Enforcement Administration (DEA) Renewal Change

*NEW* - New DEA Training Requirement

Naloxone Frequently Asked Questions (PDF)

Act 31 of 2014 Mandated Child Abuse Recognition and Reporting